Creative Medical Tech Amends 2024 10-K Filing

Ticker: CELZ · Form: 10-K/A · Filed: Mar 19, 2025 · CIK: 1187953

Sentiment: neutral

Topics: amendment, filing-correction, shares-outstanding

TL;DR

CREATIVE MEDICAL TECH AMENDS 2024 10-K TO FIX SHARE COUNT & AUDITOR DATE

AI Summary

Creative Medical Technology Holdings, Inc. filed an amendment (10-K/A) on March 19, 2025, to its annual report for the year ended December 31, 2024. This amendment corrects the number of outstanding common shares as of the original filing date and the date of the Independent Registered Accounting Firm's report.

Why It Matters

This amendment ensures the accuracy of key share count data and auditor report dates, which are crucial for investors and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is an amendment to correct minor administrative details in a previous filing, not a new disclosure of significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific information is being corrected in this 10-K/A filing?

This amendment corrects the number of shares of common stock outstanding as of the date of the Original Filing and the date of the Report of Independent Registered Accounting Firm.

When was the original 10-K filing for the fiscal year ended December 31, 2024?

The original filing was made on March 14, 2025.

What is the primary purpose of this Amendment No. 1?

The primary purpose is to correct specific details on the cover page and within the report regarding outstanding shares and the auditor's report date.

What is the fiscal year end for the report being amended?

The fiscal year end for the report is December 31, 2024.

What is the company's ticker symbol?

The filing does not explicitly state the ticker symbol, but the company name is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on March 19, 2025 regarding CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing